Dashboard
Manage Tickers

PRFX


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

painreform-announces-findings-regarding-sutures-compatibility-in-human-clinical-trials-for-prf-110
PainReform Announces Findings Regarding Su...
09/11/2024 12:33:28

painreform-shares-are-trading-lower-today-whats-going-on
PainReform Shares Are Trading Lower Today:...
09/10/2024 16:42:18

PainReform Ltd. (NASDAQ: PRFX) experienced a decline Tuesday following the company's announcement of a warrant exercise. Th...

painreform-exercise-of-warrants-for-158m-gross-proceeds
PainReform Exercise of Warrants For $1.58M...
09/10/2024 13:51:51

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
09/09/2024 12:55:05

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
09/06/2024 23:50:03

painreform-13d-filing-shows-lia-pure-capital-ltd-1-reported-a-720-stake-in-the-co-as-of-august-22-2024
PainReform 13D Filing Shows L.I.A. Pure Ca...
08/26/2024 12:19:27

- SEC Filing

painreform-confirms-optimal-delivery-method-for-prf-110-in-bunionectomy-procedures-study
PainReform Confirms Optimal Delivery Metho...
08/21/2024 12:34:40

PRF-110 Demonstrates Superior Coverage and Stability in Surgical Wounds Findings Highlight PRF-110's Competitive Edge Over ...

rainreform-shares-are-trading-higher-after-the-company-announced-early-safety-results-from-its-phase-3-bunionectomy-study-of-prf-110
RainReform shares are trading higher after...
08/20/2024 12:40:47

painreform-announces-early-safety-results-from-phase-3-bunionectomy-study-of-prf-110-says-initial-safety-data-from-the-study-revealed-a-low-incidence-of-adverse-events-averaging-just-one-per-subject
PainReform Announces Early Safety Results ...
08/20/2024 12:31:11

painreform-h1-2024-rd-expenses-114m-due-to-phase-3-trial-driving-net-loss-to-128m-ga-expenses-decrease-to-15m-cash-position-at-28m-following-4m-public-offering-in-april
PainReform H1 2024 R&D Expenses $11.4M Due...
08/15/2024 12:14:00

painreform-announces-development-and-manufacturing-of-new-formulations-providing-anti-inflammatory-and-extended-analgesic-effects
PainReform Announces Development And Manuf...
08/12/2024 13:03:05

PainReform Ltd. (NASDAQ:PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical compan...

painreform-announces-safety-data-for-prf-110-maximum-blood-levels-at-10-of-fda-safety-threshold
PainReform Announces Safety Data For PRF-1...
08/07/2024 14:01:06

painreform-announces-prf-110-promoted-normal-wound-healing-and-prevented-scar-formation-following-surgical-procedures-on-track-to-report-top-line-results-from-the-phase-3-trial-in-the-second-half-of-2024
PainReform Announces PRF-110 Promoted Norm...
08/05/2024 13:03:04

PRF-110 promoted normal wound healing and prevented scar formation following surgical procedures Company reaffirms it is on tra...

painreforms-new-manufacturing-process-achieves-18-month-stability-of-prf-110-at-room-temperature
PainReform's New Manufacturing Process Ach...
08/01/2024 12:39:41

PainReform Ltd. (NASDAQ:PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical compan...

painreform-files-patent-covering-highly-scalable-manufacturing-process-for-prf-110
PainReform Files Patent Covering Highly Sc...
07/24/2024 12:32:04

on-june-24-painreform-ilan-hadar-ceo--cfo-ceased-his-service-to-co-appointed-ehud-geller-as-interim-ceo--cfo
On June 24, PainReform Ilan Hadar, CEO & C...
06/26/2024 20:25:28

- SEC Filing

maxim-group-reiterates-buy-on-painreform-maintains-2-price-target
Maxim Group Reiterates Buy on PainReform, ...
06/26/2024 15:47:34

Maxim Group analyst Naz Rahman reiterates PainReform (NASDAQ:PRFX) with a Buy and maintains $2 price target.

painreform-completes-enrollment-in-second-part-of-its-phase-3-bunionectomy-trial-for-prf-110
PainReform Completes Enrollment In Second ...
06/26/2024 12:06:41

PainReform Ltd. (NASDAQ:PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical compan...

why-adobe-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket
Why Adobe Shares Are Trading Higher By Aro...
06/14/2024 12:19:25

why-signet-jewelers-shares-are-trading-lower-by-over-12-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Signet Jewelers Shares Are Trading Low...
06/13/2024 18:07:39

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION